title: Chemotherapy-induced hypersensitivity reactions.
abstract: OBJECTIVE
  To assist clinical nurses in understanding the complex nature of chemotherapy-induced hypersensitivity reactions as well as effectively preventing or managing these reactions.
  
  
  METHODS
  Published articles and abstracts, pertinent book chapters, computerized databases.
  
  
  RESULTS
  Most available chemotherapy drugs can cause hypersensitivity reactions, but certain drug groups frequently are associated with these reactions (e.g., asparaginases, taxanes, platinum compounds, epipodophyllotoxins). Preventing hypersensitivity reactions is the primary goal; however, understanding the principles of managing these reactions is critical because hypersensitivity reactions can occur despite using appropriate prevention strategies.
  
  
  CONCLUSIONS
  Chemotherapy-induced hypersensitivity reactions are potentially life-threatening. Nurses working with chemotherapy drugs must understand which drugs are associated with a high risk of causing hypersensitivity reactions and must be prepared to attempt to prevent or manage reactions.
  
  
  CONCLUSIONS
  The potentially life-threatening nature of hypersensitivity reactions to chemotherapy requires that nurses have a plan to manage them. This may include a written policy on staff education and training, appropriate equipment, and medications.
authors.affiliation: Northwestern Memorial Hospital, Rush University, Chicago, IL, USA. bgobel@nmh.org
authors.forename: Barbara Holmes
authors.initials: BH
authors.lastname: Gobel
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D001216:Asparagine / Q000009:adverse effects; D004342:Drug Hypersensitivity / Q000209:etiology* / Q000451:nursing / Q000517:prevention & control; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000451:nursing; D009859:Oncology Nursing / Q000379:methods; D017671:Platinum Compounds / Q000009:adverse effects; D011034:Podophyllotoxin / Q000009:adverse effects; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors; D043823:Taxoids / Q000009:adverse effects
chemical_list: D000970:Antineoplastic Agents; D017671:Platinum Compounds; D043823:Taxoids; D001216:Asparagine; D011034:Podophyllotoxin